Search

Displaying results 7251 - 7260 of 10000 in total
  1. Drug

    GMA-161

    go.drugbank.com/drugs/DB15397
    Investigational

    GMA-161 is under investigation in clinical trial NCT00244257 (Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)).

  2. Drug

    Bfpet F-18

    go.drugbank.com/drugs/DB15424
    Investigational

    Bfpet F-18 is under investigation in clinical trial NCT03265431 (Evaluation of PET/MR in Patients Selected for Ablation Therapy).

  3. Drug

    BHV-7000

    go.drugbank.com/drugs/DB22041
    Investigational

    BHV-7000 is under investigation in clinical trial NCT06419608 (Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression).

  4. Drug

    Tramazoline

    go.drugbank.com/drugs/DB13064
    Investigational

    Tramazoline is under investigation in clinical trial NCT01601509 (Nasal Tramazoline and Dexamethazone in Obstructive Sleep Apnea (OSA) Patients Tramazoline and).

  5. Drug

    nor-NOHA

    go.drugbank.com/drugs/DB02381
    Investigational

    N-Hydroxy-nor-L-arginine (nor-NOHA) is under investigation in clinical trial NCT02009527 (Arginase Inhibition in Ischemia-reperfusion Injury).

    Synonyms: N-hydroxy-nor-L-arginine, Nomega-Hydroxy-nor-L-arginine
  6. Drug

    Frespaciguat

    go.drugbank.com/drugs/DB21683
    Investigational

    Frespaciguat is a small molecule drug. The usage of the INN stem '-ciguat' in the name indicates that Frespaciguat is a guanylate cyclase activator and stimulator. … Frespaciguat is under investigation in clinical trial NCT05612035 (Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With

  7. Drug

    Plazinemdor

    go.drugbank.com/drugs/DB21493
    Investigational

    Plazinemdor is a small molecule drug. Plazinemdor is under investigation in clinical trial NCT04306146 (Study of CAD-9303 in Subjects With Schizophrenia).

  8. Drug

    Bimosiamose

    go.drugbank.com/drugs/DB06197
    Investigational

  9. Drug

    KF-0210

    go.drugbank.com/drugs/DB17476
    Investigational

    KF-0210 is a small molecule developed by Keythera Pharmaceuticals. It is being investigated for cancers.

  10. Drug

    SB-773812

    go.drugbank.com/drugs/DB16042
    Investigational

    SB-773812 is under investigation in clinical trial NCT00259870 (SB-773812 Administered in Adults With Schizophrenia).